• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

疾病负担归因于中国第一波 COVID-19 疫情,以及时机对限制流动政策成本效益的影响。

Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies.

机构信息

Department of Public Administration, College of Economics and Management, East China Normal University, Shanghai, China.

King's Health Economics, Health Service and Population Research Department, Institute of Psychiatry, Psychology, and Neuroscience at King's College London, London, UK.

出版信息

Value Health. 2021 May;24(5):615-624. doi: 10.1016/j.jval.2020.12.009. Epub 2021 Feb 21.

DOI:10.1016/j.jval.2020.12.009
PMID:33933229
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7897405/
Abstract

OBJECTIVES

Movement restriction policies (MRPs) are effective in preventing/delaying COVID-19 transmission but are associated with high societal cost. This study aims to estimate the health burden of the first wave of COVID-19 in China and the cost-effectiveness of early versus late implementation of MRPs to inform preparation for future waves.

METHODS

The SEIR (susceptible, exposed, infectious, and recovered) modeling framework was adapted to simulate the health and cost outcomes of initiating MRPs at different times: rapid implementation (January 23, the real-world scenario), delayed by 1 week, delayed by 2 weeks, and delayed by 4 weeks. The end point was set as the day when newly confirmed cases reached zero. Two costing perspectives were adopted: healthcare and societal. Input data were obtained from official statistics and published literature. The primary outcomes were disability-adjusted life-years, cost, and net monetary benefit. Costs were reported in both Chinese renminbi (RMB) and US dollars (USD) at 2019 values.

RESULTS

The first wave of COVID-19 in China resulted in 38 348 disability adjusted life-years lost (95% CI 19 417-64 130) and 2639 billion RMB losses (95% CI 1347-4688). The rapid implementation strategy dominated all other delayed strategies. This conclusion was robust to all scenarios tested. At a willingness-to-pay threshold of 70 892 RMB (the national annual GDP per capita) per disability-adjusted life-year saved, the probability for the rapid implementation to be the optimal strategy was 96%.

CONCLUSIONS

Early implementation of MRPs in response to COVID-19 reduced both the health burden and societal cost and thus should be used for future waves of COVID-19.

摘要

目的

行动限制政策(MRP)在预防/延迟 COVID-19 传播方面非常有效,但会带来高昂的社会成本。本研究旨在评估 COVID-19 在中国第一波疫情的健康负担,以及早期与晚期实施 MRP 的成本效益,以为未来波次的疫情做好准备。

方法

采用 SEIR(易感、暴露、感染和恢复)建模框架,模拟不同时间点实施 MRP 的健康和成本结果:快速实施(1 月 23 日,实际情况)、延迟 1 周、延迟 2 周和延迟 4 周。终点设定为新确诊病例清零的那一天。采用两种成本视角:医疗保健和社会。输入数据来自官方统计数据和已发表的文献。主要结果是伤残调整生命年、成本和净货币效益。成本以 2019 年的人民币(RMB)和美元(USD)报告。

结果

中国第一波 COVID-19 导致 38348 个伤残调整生命年丧失(95%CI 19417-64130)和 26390 亿元人民币损失(95%CI 1347-4688)。快速实施策略主导了所有其他延迟策略。这一结论在所有测试的情景中都具有稳健性。在 70892 元人民币(全国人均年度 GDP)每挽救一个伤残调整生命年的意愿支付阈值下,快速实施策略成为最优策略的概率为 96%。

结论

针对 COVID-19 实施早期的 MRP 可减轻健康负担和社会成本,因此应在未来的 COVID-19 波次中使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f31/7897405/4bc0baccf2d2/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f31/7897405/de5e7e618e9e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f31/7897405/aa0ef7593631/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f31/7897405/4bc0baccf2d2/gr3_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f31/7897405/de5e7e618e9e/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f31/7897405/aa0ef7593631/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2f31/7897405/4bc0baccf2d2/gr3_lrg.jpg

相似文献

1
Disease Burden Attributable to the First Wave of COVID-19 in China and the Effect of Timing on the Cost-Effectiveness of Movement Restriction Policies.疾病负担归因于中国第一波 COVID-19 疫情,以及时机对限制流动政策成本效益的影响。
Value Health. 2021 May;24(5):615-624. doi: 10.1016/j.jval.2020.12.009. Epub 2021 Feb 21.
2
Dynamic zero-COVID strategy in controlling COVID-19 in Shanghai, China: A cost-effectiveness analysis.中国上海动态清零策略控制 COVID-19 :成本效益分析。
J Infect Public Health. 2023 Jun;16(6):893-900. doi: 10.1016/j.jiph.2023.04.005. Epub 2023 Apr 11.
3
Economic burden of COVID-19, China, January-March, 2020: a cost-of-illness study.2020 年 1 月至 3 月中国 COVID-19 的经济负担:一项疾病成本研究。
Bull World Health Organ. 2021 Feb 1;99(2):112-124. doi: 10.2471/BLT.20.267112. Epub 2020 Nov 30.
4
[Cost-effectiveness and affordability of strategy for preventing mother-to-child transmission of hepatitis B in China].[中国预防乙型肝炎母婴传播策略的成本效益与可负担性]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jul 10;38(7):852-859. doi: 10.3760/cma.j.issn.0254-6450.2017.07.003.
5
Economic and epidemiological evaluation of interventions to reduce the burden of hepatitis C in Yunnan province, China.中国云南省减轻丙型肝炎负担干预措施的经济与流行病学评估
PLoS One. 2021 Jan 13;16(1):e0245288. doi: 10.1371/journal.pone.0245288. eCollection 2021.
6
Intravenous iron for the treatment of iron deficiency anemia in China: a patient-level simulation model and cost-utility analysis comparing ferric derisomaltose with iron sucrose.静脉铁剂治疗中国缺铁性贫血:铁低聚糖对比蔗糖铁的患者水平模拟模型和成本效用分析。
J Med Econ. 2022 Jan-Dec;25(1):561-570. doi: 10.1080/13696998.2022.2065092.
7
The burden of disease and the cost of illness attributable to child maltreatment in Japan: long-term health consequences largely matter.日本儿童虐待导致的疾病负担和疾病经济负担:长期健康后果至关重要。
BMC Public Health. 2020 Aug 27;20(1):1296. doi: 10.1186/s12889-020-09397-8.
8
Effectiveness and cost-effectiveness of six GLP-1RAs for treatment of Chinese type 2 diabetes mellitus patients that inadequately controlled on metformin: a micro-simulation model.基于微模拟模型的中国 2 型糖尿病患者经二甲双胍治疗控制不佳时,六种 GLP-1RA 的有效性和成本效益分析。
Front Public Health. 2023 Sep 6;11:1201818. doi: 10.3389/fpubh.2023.1201818. eCollection 2023.
9
[Cost-effectiveness of community-based treatment of chronic hepatitis B in China].[中国社区慢性乙型肝炎治疗的成本效益分析]
Zhonghua Liu Xing Bing Xue Za Zhi. 2017 Jul 10;38(7):860-867. doi: 10.3760/cma.j.issn.0254-6450.2017.07.004.
10
The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence.吸烟及降低吸烟率的经济影响:证据综述
Tob Use Insights. 2015 Jul 14;8:1-35. doi: 10.4137/TUI.S15628. eCollection 2015.

引用本文的文献

1
Granular Insights:A Wastewater-Based Machine Learning Approach for Localized COVID-19 Hospitalization Forecasting.粒度洞察:一种基于废水的机器学习方法用于局部地区新冠肺炎住院预测。
medRxiv. 2025 Jun 26:2025.06.25.25330294. doi: 10.1101/2025.06.25.25330294.
2
The burden of COVID-19 based on disability-adjusted life years: a systematic review of available evidence.基于伤残调整生命年的新冠病毒病负担:现有证据的系统评价
Front Public Health. 2025 Feb 24;13:1401726. doi: 10.3389/fpubh.2025.1401726. eCollection 2025.
3
Cost-effectiveness of preventive COVID-19 interventions: a systematic review and network meta-analysis of comparative economic evaluation studies based on real-world data.

本文引用的文献

1
Lessons from past pandemics: a systematic review of evidence-based, cost-effective interventions to suppress COVID-19.从过去的大流行病中吸取的教训:系统评价有证据支持、具有成本效益的干预措施以抑制 COVID-19。
Syst Rev. 2022 May 12;11(1):90. doi: 10.1186/s13643-022-01958-9.
2
Protocol for Prevention and Control of COVID-19 (Edition 6).新型冠状病毒肺炎防控方案(第六版)
China CDC Wkly. 2020 May 8;2(19):321-326. doi: 10.46234/ccdcw2020.082.
3
Economic burden of COVID-19, China, January-March, 2020: a cost-of-illness study.2020 年 1 月至 3 月中国 COVID-19 的经济负担:一项疾病成本研究。
2019冠状病毒病预防性干预措施的成本效益:基于真实世界数据的比较经济评估研究的系统评价与网络荟萃分析
J Glob Health. 2025 Feb 21;15:04017. doi: 10.7189/jogh.15.04017.
4
The role of economic evaluation in modelling public health and social measures for pandemic policy: a systematic review.经济评估在为大流行政策制定公共卫生和社会措施模型中的作用:一项系统综述。
Cost Eff Resour Alloc. 2024 Nov 1;22(1):77. doi: 10.1186/s12962-024-00585-6.
5
The global economic burden of COVID-19 disease: a comprehensive systematic review and meta-analysis.《COVID-19 疾病的全球经济负担:全面系统评价和荟萃分析》。
Syst Rev. 2024 Feb 16;13(1):68. doi: 10.1186/s13643-024-02476-6.
6
The optimisation of public health emergency governance: a simulation study based on COVID-19 pandemic control policy.优化公共卫生应急治理:基于 COVID-19 疫情防控政策的模拟研究。
Global Health. 2023 Dec 4;19(1):95. doi: 10.1186/s12992-023-00996-9.
7
Cost-effectiveness of Paxlovid in reducing severe COVID-19 and mortality in China.帕罗韦德在中国降低重症 COVID-19 和死亡率的成本效益。
Front Public Health. 2023 Jun 19;11:1174879. doi: 10.3389/fpubh.2023.1174879. eCollection 2023.
8
Impact of COVID-19 outbreak on the mental health in sports: a review.2019冠状病毒病疫情对体育运动中心理健康的影响:一项综述
Sport Sci Health. 2023 Apr 20:1-15. doi: 10.1007/s11332-023-01063-x.
9
Cost-effectiveness analysis of COVID-19 screening strategy under China's dynamic zero-case policy.中国动态清零政策下 COVID-19 筛查策略的成本效益分析。
Front Public Health. 2023 May 9;11:1099116. doi: 10.3389/fpubh.2023.1099116. eCollection 2023.
10
Treatment cost assessment for COVID-19 inpatients in Shenzhen, China 2020-2021: facts and suggestions.2020-2021 年中国深圳 COVID-19 住院患者的治疗费用评估:事实与建议。
Front Public Health. 2023 May 4;11:1066694. doi: 10.3389/fpubh.2023.1066694. eCollection 2023.
Bull World Health Organ. 2021 Feb 1;99(2):112-124. doi: 10.2471/BLT.20.267112. Epub 2020 Nov 30.
4
The contribution of asymptomatic SARS-CoV-2 infections to transmission on the Diamond Princess cruise ship.无症状 SARS-CoV-2 感染在“钻石公主”号邮轮上传播中的作用。
Elife. 2020 Aug 24;9:e58699. doi: 10.7554/eLife.58699.
5
The UK's public health response to covid-19.英国对新冠疫情的公共卫生应对措施。
BMJ. 2020 May 15;369:m1932. doi: 10.1136/bmj.m1932.
6
Effect of non-pharmaceutical interventions to contain COVID-19 in China.中国采取的非药物性干预措施对遏制 2019 冠状病毒病的效果。
Nature. 2020 Sep;585(7825):410-413. doi: 10.1038/s41586-020-2293-x. Epub 2020 May 4.
7
First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: a modelling impact assessment.中国湖北省以外地区采取控制措施后第一波 COVID-19 的传染性和严重程度,以及第二波疫情情景规划:模型影响评估。
Lancet. 2020 Apr 25;395(10233):1382-1393. doi: 10.1016/S0140-6736(20)30746-7. Epub 2020 Apr 8.
8
Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions.公共卫生干预下中国新冠疫情趋势的改进型SEIR模型及人工智能预测
J Thorac Dis. 2020 Mar;12(3):165-174. doi: 10.21037/jtd.2020.02.64.
9
The effectiveness of quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): A well-mixed SEIR model analysis.武汉市对 2019 年冠状病毒病(COVID-19)的隔离措施的有效性:一个混合 SEIR 模型分析。
J Med Virol. 2020 Jul;92(7):841-848. doi: 10.1002/jmv.25827. Epub 2020 Apr 25.
10
The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study.控制策略对减少社交接触以控制中国武汉 COVID-19 疫情的效果:建模研究。
Lancet Public Health. 2020 May;5(5):e261-e270. doi: 10.1016/S2468-2667(20)30073-6. Epub 2020 Mar 25.